Motokura T - Search Results

1

Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.

Oshima K, Kanda Y, Nakasone H, Arai S, Nishimoto N, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M. Oshima K, et al. Among authors: motokura t. Am J Hematol. 2008 Mar;83(3):226-32. doi: 10.1002/ajh.21087. Am J Hematol. 2008. PMID: 17918253 Free article.

2

Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.

Kako S, Izutsu K, Oshima K, Sato H, Kanda Y, Motokura T, Chiba S, Kurokawa M. Kako S, et al. Among authors: motokura t. Am J Hematol. 2007 Oct;82(10):937-9. doi: 10.1002/ajh.20943. Am J Hematol. 2007. PMID: 17663389 Free article.

3

Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab.

Kako S, Kanda Y, Oshima K, Nishimoto N, Sato H, Watanabe T, Hosoya N, Motokura T, Miyakoshi S, Taniguchi S, Kamijo A, Takahashi K, Chiba S, Kurokawa M. Kako S, et al. Among authors: motokura t. Am J Hematol. 2008 Mar;83(3):247-9. doi: 10.1002/ajh.21086. Am J Hematol. 2008. PMID: 17918251 Free article.

4

Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation.

Yoshimi A, Izutsu K, Takahashi M, Kako S, Oshima K, Kanda Y, Motokura T, Chiba S, Momose T, Ohtomo K, Kurokawa M. Yoshimi A, et al. Among authors: motokura t. Am J Hematol. 2008 Jun;83(6):477-81. doi: 10.1002/ajh.21158. Am J Hematol. 2008. PMID: 18266206 Free article.

5

Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.

Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M. Asano-Mori Y, et al. Among authors: motokura t. Am J Hematol. 2008 Jun;83(6):472-6. doi: 10.1002/ajh.21152. Am J Hematol. 2008. PMID: 18266207 Free article.

6

Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation.

Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M. Asano-Mori Y, et al. Among authors: motokura t. Int J Hematol. 2008 Apr;87(3):310-8. doi: 10.1007/s12185-008-0051-1. Epub 2008 Mar 5. Int J Hematol. 2008. PMID: 18320138

7

A myeloablative conditioning regimen for patients with impaired cardiac function undergoing allogeneic stem cell transplantation: reduced cyclophosphamide combined with etoposide and total body irradiation.

Yoshimi A, Nannya Y, Sakata-Yanagimoto M, Oshima K, Takahashi T, Kanda Y, Motokura T, Chiba S, Kurokawa M. Yoshimi A, et al. Among authors: motokura t. Am J Hematol. 2008 Aug;83(8):635-9. doi: 10.1002/ajh.21208. Am J Hematol. 2008. PMID: 18506704 Free article.

8

Late-onset pneumatosis cystoides intestinalis associated with non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation.

Suzuki HI, Izutsu K, Watanabe T, Oshima K, Kanda Y, Motokura T, Chiba S, Kurokawa M. Suzuki HI, et al. Among authors: motokura t. Int J Hematol. 2008 Jul;88(1):116-118. doi: 10.1007/s12185-008-0110-7. Epub 2008 Jun 17. Int J Hematol. 2008. PMID: 18560752 No abstract available.

9

Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin.

Komeno Y, Kanda Y, Kandabashi K, Kawazu M, Goyama S, Takeshita M, Nannya Y, Niino M, Nakamoto T, Kurokawa M, Tsujino S, Ogawa S, Aoki K, Chiba S, Motokura T, Hirai H. Komeno Y, et al. Among authors: motokura t. Am J Hematol. 2003 Mar;72(3):220-2. doi: 10.1002/ajh.10286. Am J Hematol. 2003. PMID: 12605397 Free article.

10

Pharmacokinetics of alemtuzumab after haploidentical HLA-mismatched hematopoietic stem cell transplantation using in vivo alemtuzumab with or without CD52-positive malignancies.

Oshima K, Kanda Y, Nakahara F, Shoda E, Suzuki T, Imai Y, Watanabe T, Asai T, Izutsu K, Ogawa S, Motokura T, Chiba S, Kurokawa M. Oshima K, et al. Among authors: motokura t. Am J Hematol. 2006 Nov;81(11):875-9. doi: 10.1002/ajh.20694. Am J Hematol. 2006. PMID: 16862551 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters